Cargando…
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
PURPOSE OF REVIEW: Controversy exists whether beta-blockers should be given before primary percutaneous coronary intervention (PCI) or to defer their administration for up to 24 hours. RECENT FINDINGS: Animal studies, most of them conducted in the 1970s and 1980s, showed evidence that early beta-blo...
Autores principales: | Giannakopoulos, Georgios, Noble, Stephane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105203/ https://www.ncbi.nlm.nih.gov/pubmed/33961118 http://dx.doi.org/10.1007/s11886-021-01494-3 |
Ejemplares similares
-
Predictors of Microvascular Reperfusion After Myocardial Infarction
por: Doherty, Daniel J., et al.
Publicado: (2021) -
Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease
por: Molenaar, Mitchel A., et al.
Publicado: (2022) -
Physiologic Lesion Assessment to Optimize Multivessel Disease
por: Bharmal, Murtaza, et al.
Publicado: (2022) -
Cardiac Registries During the COVID-19 Pandemic: Lessons Learned
por: Singh, Jyotpal, et al.
Publicado: (2022) -
Angiography-Based Fractional Flow Reserve: State of the Art
por: Scoccia, Alessandra, et al.
Publicado: (2022)